2011
DOI: 10.1530/eje-11-0272
|View full text |Cite
|
Sign up to set email alerts
|

The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics

Abstract: Objective: The European Registry on Cushing's syndrome (ERCUSYN) is designed to collect prospective and follow-up data at EU level on Cushing's syndrome (CS). Design and methods: Baseline data on 481 CS patients (390 females, 91 males; mean age (GS.D.): 44 G14 years) collected from 36 centres in 23 countries, including new patients from 2008 and retrospective cases since 2000. Patients were divided into four major aetiologic groups: pituitarydependent CS (PIT-CS) (66%), adrenal-dependent CS (ADR-CS) (27%), CS … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

39
266
9
11

Year Published

2014
2014
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 324 publications
(326 citation statements)
references
References 31 publications
39
266
9
11
Order By: Relevance
“…Cushing syndrome (CS) is a clinical state of prolonged exposure to inappropriately high levels of exogenous or endogenous glucocorticoids and is associated with significant morbidity and mortality (1)(2)(3)(4)(5). Surgical resection of the causal tumor(s) remains the first-line therapy for endogenous CS.…”
Section: Introductionmentioning
confidence: 99%
“…Cushing syndrome (CS) is a clinical state of prolonged exposure to inappropriately high levels of exogenous or endogenous glucocorticoids and is associated with significant morbidity and mortality (1)(2)(3)(4)(5). Surgical resection of the causal tumor(s) remains the first-line therapy for endogenous CS.…”
Section: Introductionmentioning
confidence: 99%
“…The diagnostic latency of Cushing's syndrome (CS) in general is reported with a median of 2 years in two recent studies, but studies which focus exclusively on the latency between symptom occurrence and diagnosis of pituitary-dependent CD are lacking so far (5,6). Also, no data exist which elucidate the reasons for the long diagnostic process of patients with CD or CS.…”
Section: Introductionmentioning
confidence: 99%
“…These pathognomonic signs can be detected by face classification software and could hypothetically be used for early diagnosis. Recent studies have found that CS is currently diagnosed with a latency of about 2-6 years (1,2). This may partly be due to an overlap of clinical features with the more common metabolic syndrome.…”
Section: Introductionmentioning
confidence: 99%